Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ondansetron Hydrochloride Injection

Approval Number

国药准字H19980012

Company常州兰陵制药有限公司

Registration Date

August 13, 2020

Drug Information

Generic Name

盐酸昂丹司琼注射液

Trade Name

富米汀

Dosage Form

注射剂

Strength

按C18H19N3O计 2ml:4mg

Drug Type

化学药品

Registration Date

August 13, 2020

Company Information

Applicant Company

Company Name常州兰陵制药有限公司

Company Address

常州市劳动东路352号

Manufacturing Company

Company Name常州兰陵制药有限公司

Company Address

常州市劳动东路352号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

盐酸昂丹司琼注射液 - NMPA 批准文号 | MedPath